Speciality Medicines Ltd finalized a commercial arrangement with an international entity for distribution of pharmaceutical products.
The deal involves distribution of products worth USD 1.5 million (approximately ₹14 crores) under mutually agreed terms.
The arrangement is expected to significantly enhance the company's distribution network and revenue visibility.
The transaction does not involve promoters or related parties and is not classified as a related party transaction.